These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Amprenavir study results released. AIDS Patient Care STDS; 1999 Dec; 13(12):754. PubMed ID: 10743545 [No Abstract] [Full Text] [Related]
4. Amprenavir (Agenerase) now available in expanded access. AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864 [TBL] [Abstract][Full Text] [Related]
5. Amprenavir: a new HIV protease inhibitor. Med Lett Drugs Ther; 1999 Jul; 41(1057):64-6. PubMed ID: 10436772 [No Abstract] [Full Text] [Related]
10. [Maintaining independence. New protease inhibitor receives drug approval recommendation]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():84-5. PubMed ID: 15373062 [No Abstract] [Full Text] [Related]
11. Human immunodeficiency virus type 1 hypersusceptibility to amprenavir in vitro can be associated with virus load response to treatment in vivo. Zachary KC; Hanna GJ; D'Aquila RT Clin Infect Dis; 2001 Dec; 33(12):2075-7. PubMed ID: 11700580 [TBL] [Abstract][Full Text] [Related]
12. HIV protease mutations associated with amprenavir resistance during salvage therapy: importance of I54M. Murphy MD; Marousek GI; Chou S J Clin Virol; 2004 May; 30(1):62-7. PubMed ID: 15072756 [TBL] [Abstract][Full Text] [Related]
13. New treatment options. Fornataro K; Jefferys R Body Posit; 1999 Jun; 12(6):11-2. PubMed ID: 11367013 [TBL] [Abstract][Full Text] [Related]
15. Experimental drug available. Vazquez E Posit Aware; 1998; 9(6):17. PubMed ID: 11366472 [TBL] [Abstract][Full Text] [Related]
16. Amprenavir, new protease inhibitor, approved. James JS AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454 [TBL] [Abstract][Full Text] [Related]
17. Patients sought for ACTU studies that will help answer questions about drugs. Fac Notes (New Orleans La); 1998; 10(6):6. PubMed ID: 11366145 [TBL] [Abstract][Full Text] [Related]